Zymeworks Inc (ZYME)
8.72
+0.01
(+0.11%)
USD |
NASDAQ |
May 24, 16:00
8.725
0.00 (0.00%)
After-Hours: 20:00
Zymeworks Cash from Financing (Quarterly): 2.123M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.123M |
| December 31, 2023 | 50.61M |
| September 30, 2023 | 1.896M |
| June 30, 2023 | 27.60M |
| March 31, 2023 | 1.738M |
| December 31, 2022 | -0.377M |
| September 30, 2022 | 0.628M |
| June 30, 2022 | -0.279M |
| March 31, 2022 | 108.61M |
| December 31, 2021 | 0.689M |
| September 30, 2021 | 4.545M |
| June 30, 2021 | 0.671M |
| March 31, 2021 | 2.106M |
| December 31, 2020 | 2.694M |
| September 30, 2020 | 3.247M |
| June 30, 2020 | 0.205M |
| March 31, 2020 | 302.83M |
| Date | Value |
|---|---|
| December 31, 2019 | 2.158M |
| September 30, 2019 | 0.999M |
| June 30, 2019 | 189.94M |
| March 31, 2019 | 0.569M |
| December 31, 2018 | -0.146M |
| September 30, 2018 | -0.905M |
| June 30, 2018 | 92.35M |
| March 31, 2018 | 0.131M |
| December 31, 2017 | 0.125M |
| September 30, 2017 | -0.162M |
| June 30, 2017 | 50.00M |
| March 31, 2017 | -0.015M |
| December 31, 2016 | -1.294M |
| September 30, 2016 | -0.231M |
| June 30, 2016 | 7.247M |
| March 31, 2016 | 59.06M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.377M
Minimum
Dec 2022
302.83M
Maximum
Mar 2020
35.13M
Average
2.114M
Median
Cash from Financing (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 40.70M |
| Regeneron Pharmaceuticals Inc | 47.10M |
| MariMed Inc | 1.645M |
| Viemed Healthcare Inc | -1.34M |
| NovaBay Pharmaceuticals Inc | -0.597M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -37.67M |
| Cash from Investing (Quarterly) | -7.316M |
| Free Cash Flow | -77.13M |
| Free Cash Flow Per Share (Quarterly) | -0.5026 |
| Free Cash Flow to Equity (Quarterly) | -38.32M |
| Free Cash Flow to Firm (Quarterly) | -38.32M |
| Free Cash Flow Yield | -12.42% |